File this under “Not every legal brief is eye-glazing.”
Two months ago, Pacira Biosciences (PCRX) took the highly unusual step of filing a libel lawsuit against a medical journal, its editor, and the authors of several published papers, arguing the articles were based on “faulty scientific research” and as a result, its only medicine was portrayed as ineffective.
About the Author Reprints
Create a display name to comment
This name will appear with your comment
